Suspensión de Antirresortivos en Osteonecrosis Asociada a Medicamentos
Revisión de la Literatura
Palabras clave:
Osteonecrosis, Antirresortivos, Maxilares, Prevencion, SuspensiónResumen
La suspensión de antirresortivos en el contexto de cuadros de osteonecrosis asociada a medicamentos (ONAM) es controversial. Aunque la evidencia de calidad al respecto es insuficiente, múltiples sociedades profesionales y grupos de trabajo han sugerido emplear este recurso. Recientemente la Sociedad Americana de Cirujanos Orales y Maxilofaciales ha puesto en duda sus beneficios. En el presente estudio abordamos esta temática en dos situaciones clínicas diferentes. Por un lado, analizamos la suspensión de los antirresortivos en pacientes asintomáticos antes de llevar a cabo procedimientos invasivos en los maxilares para disminuir el riesgo de desarrollo de ONAM. Por otro lado, evaluamos la suspensión de los antirresortivos en pacientes con ONAM establecida para mejorar el pronóstico de la enfermedad.
Citas
Bennett, J. E., Dolin, R., y Blaser, M. J. (2014). Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. (8va ed.). (vol 2). Elsevier Health Sciences.
Black, D. M., y Rosen, C. J. (2016). Clinical practice. Postmenopausal osteoporosis. The New England Journal of Medicine, 374(3), 254–262. https://doi.org/10.1056/NEJMcp1513724
Campisi, G., Mauceri, R., Bertoldo, F., Bettini, G., Biasotto, M., Colella, G., Consolo, U., Di Fede, O., Favia, G., Fusco, V., Gabriele, M., Lo Casto, A., Lo Muzio, L., Marcianò, A., Mascitti, M., Meleti, M., Mignogna, M. D., Oteri, G., Panzarella, V., Romeo, U., … Bedogni, A. (2020). Medication-Related Osteonecrosis of Jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020. International Journal of Environmental Research and Public Health, 17(16), 5998. https://doi.org/10.3390/ijerph17165998
Delmas, P. D., y Meunier, P. J. (1997). The management of Paget's disease of bone. The New England Journal of Medicine, 336(8), 558–566. https://doi.org/10.1056/NEJM199702203360807
Hayashida, S., Yanamoto, S., Fujita, S., Hasegawa, T., Komori, T., Kojima, Y., Miyamoto, H., Shibuya, Y., Ueda, N., Kirita, T., Nakahara, H., Shinohara, M., Kondo, E., Kurita, H., y Umeda, M. (2020). Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw. Journal of Bone and Mineral Metabolism, 38(1), 126–134. https://doi.org/10.1007/s00774-019-01035-7
Hinson, A. M., Siegel, E. R., y Stack, B. C., Jr (2015). Temporal correlation between bisphosphonate termination and symptom resolution in osteonecrosis of the jaw: a pooled case report analysis. Journal of Oral and Maxillofacial Surgery, 73(1), 53–62. https://doi.org/10.1016/j.joms.2014.07.012
Japanese Allied Committee on Osteonecrosis of the Jaw, Yoneda, T., Hagino, H., Sugimoto, T., Ohta, H., Takahashi, S., Soen, S., Taguchi, A., Nagata, T., Urade, M., Shibahara, T., y Toyosawa, S. (2017). Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw. Journal of Bone and Mineral Metabolism, 35(1), 6–19. https://doi.org/10.1007/s00774-016-0810-7
Johnston, C. B., y Dagar, M. (2020). Osteoporosis in older adults. The Medical Clinics of North America, 104(5), 873–884. https://doi.org/10.1016/j.mcna.2020.06.004
Khan, A. A., Morrison, A., Hanley, D. A., Felsenberg, D., McCauley, L. K., O'Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., Watts, N. B., Brandi, M. L., Peters, E., Guise, T., Eastell, R., Cheung, A. M., Morin, S. N., Masri, B., Cooper, C., Morgan, S. L., … International Task Force on Osteonecrosis of the Jaw (2015). Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. Journal of Bone and Mineral Research, 30(1), 3–23. https://doi.org/10.1002/jbmr.2405
Khan, A. A., Morrison, A., Kendler, D. L., Rizzoli, R., Hanley, D. A., Felsenberg, D., McCauley, L. K., O'Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., Watts, N. B., Brandi, M. L., Peters, E., Guise, T., Eastell, R., Cheung, A. M., Morin, S. N., Masri, B., … International Task Force on Osteonecrosis of the Jaw (2017). Case-based review of Osteonecrosis of the Jaw (ONJ) and application of the International Recommendations for Management from the International Task Force on ONJ. Journal of Clinical Densitometry, 20(1), 8–24. https://doi.org/10.1016/j.jocd.2016.09.005
Kim, Y. H., Lee, H. K., Song, S. I., y Lee, J. K. (2014). Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw. Journal of the Korean Association of Oral and Maxillofacial Surgeons, 40(5), 206–210. https://doi.org/10.5125/jkaoms.2014.40.5.206
Letocha, A. D., Cintas, H. L., Troendle, J. F., Reynolds, J. C., Cann, C. E., Chernoff, E. J., Hill, S. C., Gerber, L. H., y Marini, J. C. (2005). Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement. Journal of Bone and Mineral Research, 20(6), 977–986. https://doi.org/10.1359/JBMR.050109
Magopoulos, C., Karakinaris, G., Telioudis, Z., Vahtsevanos, K., Dimitrakopoulos, I., Antoniadis, K., y Delaroudis, S. (2007). Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. American Journal of Otolaryngology, 28(3), 158–163. https://doi.org/10.1016/j.amjoto.2006.08.004
Martins, A. S., Correia, J. A., Salvado, F., Caldas, C., Santos, N., Capelo, A., y Palmela, P. (2017). Relevant factors for treatment outcome and time to healing in medication-related osteonecrosis of the jaws - A retrospective cohort study. Journal of Cranio-Maxillo-Facial Surgery, 45(10), 1736–1742. https://doi.org/10.1016/j.jcms.2017.07.014
Otsuru, M., Soutome, S., Omori, K., Suyama, K., Morishita, K., Hayashida, S., Murata, M., Takagi, Y., Sasaki, M., Sumi, M., Kojima, Y., Sawada, S., Sakamoto, Y., y Umeda, M. (2022). Relationship between drug holidays of antiresorptive agents and surgical outcomes in cancer patients with medication-related osteonecrosis of the jaw. International Journal of Environmental Research and Public Health, 19(8), 4624. https://doi.org/10.3390/ijerph19084624
Ottesen, C., Schiodt, M., y Gotfredsen, K. (2020). Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): a systematic review. Heliyon, 6(4), e03795. https://doi.org/10.1016/j.heliyon.2020.e03795
Ruggiero, S. L., Dodson, T. B., Aghaloo, T., Carlson, E. R., Ward, B. B., y Kademani, D. (2022). American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update. Journal of Oral and Maxillofacial Surgery, 80(5), 920–943. https://doi.org/10.1016/j.joms.2022.02.008
Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., O'Ryan, F., y American Association of Oral and Maxillofacial Surgeons (2014). American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. Journal of Oral and Maxillofacial Surgery, 72(10), 1938–1956. https://doi.org/10.1016/j.joms.2014.04.031
Sawada, S., Sakamoto, Y., Kirihigashi, M., Kojima, Y. (2023). Drug holiday of high-dose denosumab and recovery from osteoclast inhibition using immunohistochemical investigation of 7 patients with medication-related osteonecrosis of the jaw undergoing segmental mandibulectomy. Journal of Dental Sciences, 18(4), 1645–1650, https://doi.org/10.1016/j.jds.2023.01.021
Schwartz, E., Reichert, Z., y Van Poznak, C. (2022). Pharmacologic management of metastatic bone disease. Bone, 158, 115735. https://doi.org/10.1016/j.bone.2020.115735
Stewart A. F. (2005). Clinical practice. Hypercalcemia associated with cancer. The New England Journal of Medicine, 352(4), 373–379. https://doi.org/10.1056/NEJMcp042806
Yarom, N., Shapiro, C. L., Peterson, D. E., Van Poznak, C. H., Bohlke, K., Ruggiero, S. L., Migliorati, C. A., Khan, A., Morrison, A., Anderson, H., Murphy, B. A., Alston-Johnson, D., Mendes, R. A., Beadle, B. M., Jensen, S. B., y Saunders, D. P. (2019). Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline. Journal of Clinical Oncology, 37(25), 2270–2290. https://doi.org/10.1200/JCO.19.01186
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Revista de la Facultad de Odontologia de la Universidad de Buenos Aires
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
